Dr. Paul Watkins to Speak at Reactive Metabolites Conference

Dr. Paul Watkins, director of The Hamner-University of North Carolina Institute for Drug Safety Sciences, will be leading a session entitled "Regulatory actions based on liver safety: Impact of reactive metabolite screening" at the 2nd Mitigation Strategies for Reactive Metabolites Conference on November 28, 2012 in Boston, MA.